Necrotizing fasciitis secondary to bevacizumab treatment for metastatic rectal adenocarcinoma

Bevacizumab is a recombinant humanized monoclonal antibody that selectively blocks the activity of vascular endothelial growth factor (VEGF) receptor and it is used in metastatic colorectal patients. We present here a case of fatal necrotizing fasciitis in a patient during bevacizumab treatment for...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Şendur, Mehmet A. N., Aksoy, Sercan, Özdemir, Nuriye Yıldırım, Zengin, Nurullah
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Medknow Publications & Media Pvt Ltd 2014
Konular:
Drug Watch
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3912798/
https://ncbi.nlm.nih.gov/pubmed/24550600
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0253-7613.125195
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller